3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Pseudomyxoma Peritonei
1
Mesothelioma, Malignant
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Appendiceal Neoplasms
1
Advanced Cancer
1
Interventions
Cytoreduction Surgical Procedures
2
Cyclophosphamide
2
Cisplatin
2
sodium thiosulfate
1
sargramostim
1
pembrolizumab
1
fludarabine
1
entinostat
1
X-Rays
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Specimen Handling
1
Referral and Consultation
1
Quality of Life
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Platinum
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Molecular Diagnostic Techniques
1
Microarray Analysis
1
Magnetic Resonance Spectroscopy
1
Interleukin-12 Subunit p35
1
Interferon-gamma
1
Interferon-alpha
1
Immunotherapy
1
Immunoenzyme Techniques
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gene Expression Profiling
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Referral and Consultation
×
Other solid neoplasm
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled